Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Alzheimer's Disease Is a Synaptic Failure

Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736 · see citing works

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

Lupski, J. R., Montes‐de‐Oca‐Luna, R., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B. J., Cárdenas, O. S., Barker, D. F., Killian, J. M., Garcia, C. A., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90613-4 · Cited by 1,333 · see citing works

Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair

Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284 · see citing works

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249 · see citing works

Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease

Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · see citing works

Alzheimer’s disease

Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152 · see citing works

Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins

Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works

Down syndrome phenotypes: the consequences of chromosomal imbalance.

Korenberg, J. R., Chen, X. N., Schipper, R. D., Sun, Z., Gonsky, R., Gerwehr, S., Carpenter, N. J., Däumer, C., Dignan, P. S. J., & Distèche, C. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4997 · Cited by 784 · see citing works

Molecular pathways to neurodegeneration

Bossy-Wetzel, E., Schwarzenbacher, R., & Lipton, S. A. (2004) · Nature Medicine · doi:10.1038/nm1067 · Cited by 740 · see citing works

Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 669 · see citing works

Duplication of the MECP2 Region Is a Frequent Cause of Severe Mental Retardation and Progressive Neurological Symptoms in Males

Esch, H. V., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., Lugtenberg, D., Bienvenu, T., Jensen, L. R., Gécz, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/444549 · Cited by 630 · see citing works

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 1× · see citing works

MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS

Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 568 · see citing works

A Prospective Study of Alzheimer Disease in Down Syndrome

Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561 · see citing works

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · see citing works

NGF Signaling in Sensory Neurons

Delcroix, J., Valletta, J. S., Wu, C., Hunt, S. J., Kowal, A. S., & Mobley, W. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00397-0 · Cited by 455 · see citing works

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448 · see citing works

Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR

Golde, T. E., Estus, S., Usiak, M., Younkin, L. H., & Younkin, S. G. (1990) · Neuron · doi:10.1016/0896-6273(90)90100-t · Cited by 431 · see citing works

Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila

Gunawardena, S., & Goldstein, L. S. B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00496-2 · Cited by 428 · see citing works

Alzheimer's disease in Down's syndrome: Clinicopathologic studies

Wisniewski, K. E., Dalton, A. J., McLachlan, D. R. C., Wen, G. Y., & Wisniewski, H. M. (1985) · Neurology · doi:10.1212/wnl.35.7.957 · Cited by 417 · see citing works

Molecular mapping of alzheimer‐type dementia in Down's syndrome

Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414 · see citing works

Functions and mechanisms of retrograde neurotrophin signalling

Zweifel, L. S., Kuruvilla, R., & Ginty, D. D. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1727 · Cited by 413 · see citing works

Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities

Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6256 · Cited by 382 · see citing works

Untitled work

(1990) · PubMed · Cited by 351 · see citing works

Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · see citing works

Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice

Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., & Gearhart, J. D. (1993) · Nature Genetics · doi:10.1038/ng0993-22 · Cited by 311 · see citing works

Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome

Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297 · see citing works

Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains

Hof, P. R. (2000) · Elsevier eBooks · Cited by 289 · see citing works

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 279 · see citing works

Nerve Growth Factor Activates Persistent Rap1 Signaling in Endosomes

Wu, C., Lai, C.-F., & Mobley, W. C. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05406.2001 · Cited by 250 · see citing works

<i>App</i>Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 4× · see citing works

NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum

Gage, F. H., Batchelor, P., Chen, K. S., Chin, D. E., Higgins, G. A., Koh, S., Deputy, S. R., Rosenberg, M. B., Fischer, W., & Björklund, A. (1989) · Neuron · doi:10.1016/0896-6273(89)90184-0 · Cited by 241 · see citing works

Endocytosis of Functional Epidermal Growth Factor Receptor-Green Fluorescent Protein Chimera

Carter, R. E., & Sorkin, A. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35000 · Cited by 235 · see citing works

Evidence in Support of Signaling Endosome-Based Retrograde Survival of Sympathetic Neurons

Ye, H., Kuruvilla, R., Zweifel, L. S., & Ginty, D. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00266-6 · Cited by 233 · see citing works

Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits

Chen, K. S., Nishimura, M. C., Armanini, M. P., Crowley, C. W., Spencer, S. D., & PHILLIPS, H. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07288.1997 · Cited by 227 · see citing works

Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain

Petanceska, S. S., Nagy, V., Frail, D. E., & Gandy, S. (2000) · Neurology · doi:10.1212/wnl.54.12.2212 · Cited by 225 · see citing works

Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions

Gardiner, K., Fortna, A., Bechtel, L. J., & Davisson, M. T. (2003) · Gene · doi:10.1016/s0378-1119(03)00769-8 · Cited by 207 · see citing works

Absence of p75NTRCauses Increased Basal Forebrain Cholinergic Neuron Size, Choline Acetyltransferase Activity, and Target Innervation

Yeo, T. T. S., Chua-Couzens, J., Butcher, L. L., Bredesen, D. E., Cooper, J. D., Valletta, J. S., Mobley, W. C., & Longo, F. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07594.1997 · Cited by 206 · see citing works

TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons

Holtzman, D. M., Kilbridge, J. F., Li, Y., Cunningham, E. T., Lenn, N., Clary, D. O., Reichardt, L. F., & Mobley, W. C. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01567.1995 · Cited by 192 · see citing works

Ligand-Induced Internalization of the p75 Neurotrophin Receptor: A Slow Route to the Signaling Endosome

Bronfman, F. C., Tcherpakov, M., Jovin, T. M., & Fainzilber, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03209.2003 · Cited by 190 · see citing works

APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1

Jankowsky, J. L., Slunt, H. H., Gonzales, V., Jenkins, N. A., Copeland, N. G., & Borchelt, D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.008 · Cited by 189 · see citing works

Signaling endosome hypothesis: A cellular mechanism for long distance communication

Howe, C. L., & Mobley, W. C. (2003) · Journal of Neurobiology · doi:10.1002/neu.10323 · Cited by 185 · see citing works

Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3

Sofroniew, M. V., Cooper, J. D., Svendsen, C., Crossman, P., Ip, N. Y., Lindsay, R. M., Zafra, F., & Lindholm, D. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05263.1993 · Cited by 165 · see citing works

Localization and development of nerve growth factor-sensitive rat basal forebrain neurons and their afferent projections to hippocampus and neocortex

Koh, S., & Loy, R. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-09-02999.1989 · Cited by 147 · see citing works

Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells

Sambamurti, K., Shioi, J., Anderson, J. P., Pappolla, M. A., & Robakis, N. K. R. K. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330216 · Cited by 144 · see citing works

A Novel γ-Secretase Assay Based on Detection of the Putative C-terminal Fragment-γ of Amyloid β Protein Precursor

Pinnix, I., Musunuru, U., Tun, H. W., Sridharan, A., Golde, T. E., Eckman, C. B., Ziani‐Cherif, C., Onstead, L., & Sambamurti, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005968200 · Cited by 138 · see citing works

Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein

Cai, D., Leem, J. Y., Greenfield, J. P., Wang, P., Kim, B. S., Wang, R., Radomski, K. L., Kim, S.-H., Zheng, H., Greengard, P., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209065200 · Cited by 132 · see citing works

Traffic at the intersection of neurotrophic factor signaling and neurodegeneration

Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131 · see citing works

Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice

Lamb, B. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1535 · Cited by 128 · see citing works

Fluro-Gold: composition, and mechanism of uptake

Wessendorf, M. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90241-m · Cited by 127 · see citing works

Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated trka expression in the medial septum of aged rats

Cooper, J. D., Lindholm, D., & Sofroniew, M. V. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90462-6 · Cited by 116 · see citing works

Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice

Seo, H., & Ole Isacson, A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.017 · Cited by 112 · see citing works

Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus

Salehi, A., Lucassen, P. J., Pool, C. W., Gonatas, N. K., Ravid, R., & Swaab, D. F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90291-7 · Cited by 98 · see citing works

PATHOLOGICAL EVIDENCE FOR NEUROTRANSMITTER DEFICITS IN DOWN'S SYNDROME OF MIDDLE AGE

Mann, D. M. A., Yates, P. O., Marcyniuk, B., & Ravindra, C. (1985) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1985.tb00320.x · Cited by 97 · see citing works

Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway

Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 91 · see citing works

Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor.

Yamada, T., Sasaki, H., Doh-ura, K., Goto, I., & Sakaki, Y. (1989) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/0006-291x(89)92808-8 · Cited by 88 · see citing works

Do Disorders of Movement Cause Movement Disorders and Dementia?

Goldstein, L. S. B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00630-5 · Cited by 79 · see citing works

Endofin, an Endosomal FYVE Domain Protein

Seet, L., & Hong, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105917200 · Cited by 75 · see citing works

Mice Deficient for the Amyloid Precursor Protein Gene

Zheng, H., Jiang, M., Trumbauer, M. E., Hopkins, R., SIRINATHSINGHJI, D. J. S., Stevens, K. A., Conner, M. W., Slunt, H. H., Sisodia, S. S., Chen, H. Y., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34456.x · Cited by 74 · see citing works

Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus

Cobb, S. R., Bulters, D. O., Suchak, S. K., Riedel, G., Morris, R., & Davies, C. H. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0131r.x · Cited by 68 · see citing works

Correction: Corrigendum: Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice

(1993) · Nature Genetics · doi:10.1038/ng1193-312d · Cited by 65 · see citing works

Trafficking the NGF signal: implications for normal and degenerating neurons

Delcroix, J., Valletta, J. S., Wu, C., Howe, C. L., Lai, C.-F., Cooper, J. D., Belichenko, P. V., Salehi, A., & Mobley, W. C. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46001-9 · Cited by 57 · see citing works

Additional Copies of the Proteolipid Protein Gene Causing Pelizaeus-Merzbacher Disease Arise by Separate Integration into the X Chromosome

Hodes, M. E., Woodward, K. J., Spinner, N. B., Emanuel, B. S., Enrico-Simon, A., Kamholz, J. A., Stambolian, D. E., Zackai, E. H., Pratt, V. M., Thomas, I. T., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302965 · Cited by 50 · see citing works

A low-affinity nerve growth factor receptor antibody is internalized and retrogradely transported selectively into cholinergic neurons of the rat basal forebrain

Kiss, J., Shooter, E. M., & Patel, A. J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90063-l · Cited by 20 · see citing works

Neurodegenerative Diseases Target Large-Scale Human Brain Networks

Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · see citing works

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · see citing works

Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease

Hirokawa, N., Niwa, S., & Tanaka, Y. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.039 · Cited by 1,138 · see citing works

APP processing in Alzheimer’s disease.

Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983 · see citing works

Down syndrome

Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0143-7 · Cited by 964 · see citing works

Axonal transport deficits and neurodegenerative diseases

Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755 · see citing works

Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline

Ballinger, E. C., Ananth, M. R., Talmage, D. A., & Role, L. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.006 · Cited by 735 · see citing works

Role of Axonal Transport in Neurodegenerative Diseases

Vos, K. J. D., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 734 · see citing works

Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome

Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.004 · Cited by 706 · see citing works

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562 · see citing works

Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis

Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., Wu, J. Y., & Finkbeiner, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4988-09.2010 · Cited by 554 · see citing works

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · see citing works

Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection

Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7260130 · Cited by 456 · see citing works

Alzheimer disease models and human neuropathology: similarities and differences

Duyckaerts, C. J., Potier, M., & Delatour, B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 441 · see citing works

Axonal transport and neurodegenerative disease

Chevalier-Larsen, E. S., & Holzbaur, E. L. F. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.04.002 · Cited by 438 · see citing works

Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques

Gowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., & Ferguson, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510329112 · Cited by 406 · see citing works

Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease

Nixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400 · see citing works

Dementia in Down syndrome: unique insights for Alzheimer disease research

Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383 · see citing works

“Down syndrome: an insight of the disease”

Asim, A., Kumar, A., Muthuswamy, S., Jain, S., & Agarwal, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0138-y · Cited by 380 · see citing works

One at a time, live tracking of NGF axonal transport using quantum dots

Cui, B., Wu, C., Chen, L., Ramı́rez, A., Bearer, E. L., Li, W., Mobley, W. C., & Chu, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706192104 · Cited by 364 · see citing works

Neurodegenerative lysosomal disorders: A continuum from development to late age

Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362 · see citing works

Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology

Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355 · see citing works

Neurotrophic factors in Alzheimer’s disease: role of axonal transport

Schindowski, K., Bélarbi, K., & Buée, L. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00378.x · Cited by 335 · see citing works

Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling

Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00170 · Cited by 330 · see citing works

Nurturing brain plasticity: Impact of environmental enrichment

Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Sale, A., & Maffei, L. (2010) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2009.193 · Cited by 330 · see citing works

Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain

Andres, R. H., Horie, N., Slikker, W., Keren-Gill, H., Zhan, K., Sun, G., Manley, N. C., Pereira, M. P., Sheikh, L. A., McMillan, E. L., et al. (2011) · Brain · doi:10.1093/brain/awr094 · Cited by 329 · see citing works

Down syndrome and the complexity of genome dosage imbalance

Antonarakis, S. (2016) · Nature reviews genetics · doi:10.1038/nrg.2016.154 · Cited by 264 · see citing works

Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition

Jiang, Y., Mullaney, K. A., Peterhoff, C. M., Che, S., Schmidt, S. D., Boyer‐Boiteau, A., Ginsberg, S. D., Cataldo, A. M., Mathews, P. M., & Nixon, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908953107 · Cited by 288 · see citing works

Down syndrome and Alzheimer's disease: common pathways, common goals

Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290 · see citing works

Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders

Lee, J. A., & Lupski, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.027 · Cited by 289 · see citing works

Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis

Pimplikar, S. W., Nixon, R. A., Robakis, N. K. R. K., Shen, J., & Tsai, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4305-10.2010 · Cited by 281 · see citing works

Long-distance retrograde neurotrophic factor signalling in neurons

Harrington, A., & Ginty, D. D. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3253 · Cited by 269 · see citing works

Lysosome trafficking and signaling in health and neurodegenerative diseases

Lie, P. P. Y., & Nixon, R. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.015 · Cited by 269 · see citing works

Molecular nexopathies: a new paradigm of neurodegenerative disease

Warren, J. D., Rohrer, J. D., Schott, J. M., Fox, N. C., Hardy, J., & Rossor, M. N. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.007 · Cited by 268 · see citing works

The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome

Mégarbané, A., Ravel, A., Mircher, C., Sturtz, F. G., Grattau, Y., Rethoré, M. O., Delabar, J. M., & Mobley, W. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2e34c · Cited by 261 · see citing works

The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes

Nhan, H. S., Chiang, K., & Koo, E. H. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1347-2 · Cited by 256 · see citing works

Down syndrome--recent progress and future prospects

Wiseman, F. K., Alford, K. A., Tybulewicz, V. L. J., & Fisher, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp010 · Cited by 247 · see citing works

Cellular Functions of the Amyloid Precursor Protein from Development to Dementia

van der Kant, R., & Goldstein, L. S. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.022 · Cited by 246 · see citing works

Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease

TCW, J., & Goate, A. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024539 · Cited by 242 · see citing works

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions

Yu, T., Li, Z., Jia, Z., Clapcote, S. J., Liu, C., Li, S., Asrar, S., Pao, A., Chen, R., Fan, N., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq179 · Cited by 238 · see citing works

Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1*

Zoghbi, H., & Orr, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800041200 · Cited by 228 · see citing works

Neurological phenotypes for Down syndrome across the life span

Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225 · see citing works

Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome

Duchon, A., Raveau, M., Chevalier, C., Nalesso, V., Sharp, A. J., & Herault, Y. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9356-0 · Cited by 224 · see citing works

Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care

Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., Miguel, Z. D., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 224 · see citing works

Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer’s disease

Kim, S., Sato, Y., Mohan, P. S., Peterhoff, C. M., Pensalfini, A., Rigoglioso, A., Jiang, Y., & Nixon, R. A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.97 · Cited by 220 · see citing works

Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease

Peng, S., Garzon, D. J., Marchese, M., Klein, W. L., Ginsberg, S. D., Francis, B. M., Mount, H. T. J., Mufson, E. J., Salehi, A., & Fahnestock, M. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4736-08.2009 · Cited by 216 · see citing works

GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment

Xu, Y., Zhao, M., Han, Y., & Zhang, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00660 · Cited by 203 · see citing works

Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype‐phenotype relationships

Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J., & Mobley, W. C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21433 · Cited by 202 · see citing works

Rodent models in Down syndrome research: impact and future opportunities

Hérault, Y., Delabar, J. M., Fisher, E., Tybulewicz, V. L. J., Yu, E. Y., & Brault, V. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029728 · Cited by 191 · see citing works

Trisomy 21 and early brain development

Haydar, T. F., & Reeves, R. H. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.001 · Cited by 200 · see citing works

β-Amyloid impairs axonal BDNF retrograde trafficking

Poon, W. W., Blurton-Jones, M. M., Tu, C. H., Feinberg, L. M., Chabrier, M. A., Harris, J. W., Jeon, N. L., & Cotman, C. W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.012 · Cited by 198 · see citing works

Neurotrophins, synaptic plasticity and dementia

Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 193 · see citing works

Reimagining cholinergic therapy for Alzheimer’s disease

Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187 · see citing works

Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology

Cataldo, A. M., Mathews, P. M., Boyer‐Boiteau, A., Hassinger, L. C., Peterhoff, C. M., Jiang, Y., Mullaney, K. A., Neve, R. L., Gruenberg, J. E., & Nixon, R. A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071053 · Cited by 188 · see citing works

Development and validation of the Arizona Cognitive Test Battery for Down syndrome

Edgin, J. O., Mason, G. M., Allman, M. J., Capone, G. T., DeLeon, I. G., Maslen, C. L., Reeves, R. H., Sherman, S. L., & Nadel, L. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9054-3 · Cited by 182 · see citing works

Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support

Marsh, S. E., & Blurton-Jones, M. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.006 · Cited by 182 · see citing works

DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome

Duchon, A., & Herault, Y. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00104 · Cited by 181 · see citing works

Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration

Xu, W. L., Weissmiller, A. M., White, J. A., Fang, F., Wang, X., Wu, Y., Pearn, M. L., Zhao, X., Sawa, M., Chen, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82409 · Cited by 181 · see citing works

Trisomy for the Down syndrome ‘critical region’ is necessary but not sufficient for brain phenotypes of trisomic mice

Olson, L. E., Roper, R. J., Sengstaken, C. L., Peterson, E. A., Aquino, V. N., Galdzicki, Z., Siarey, R. J., Pletnikov, M. V., Moran, T. H., & Reeves, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm022 · Cited by 178 · see citing works

The Neurotrophins and Their Role in Alzheimers Disease

Allen, S. J., Watson, J. J., & Dawbarn, D. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376190 · Cited by 177 · see citing works

Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses

Chen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00446 · Cited by 174 · see citing works

All-you-can-eat: autophagy in neurodegeneration and neuroprotection

Jaeger, P. A., & Wyss‐Coray, T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-16 · Cited by 175 · see citing works

Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome

Voronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., Schmidt, C., Akeson, E. C., Wenk, M. R., Cimasoni, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803756105 · Cited by 174 · see citing works

Mouse models of Down syndrome: gene content and consequences

Gupta, M., Dhanasekaran, A. R., & Gardiner, K. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9661-8 · Cited by 167 · see citing works

Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities

Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171 · see citing works

NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons

Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806133105 · Cited by 169 · see citing works

DYRK1A and cognition: A lifelong relationship

Arbonés, M. L., Thomazeau, A., Nakano-Kobayashi, A., Hagiwara, M., & Delabar, J. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.010 · Cited by 165 · see citing works

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Vogel, J. W., Corriveau‐Lecavalier, N., Franzmeier, N., Pereira, J. B., Brown, J. A., Maaß, A., Botha, H., Seeley, W. W., Bassett, D. S., Jones, D. T., et al. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00731-8 · Cited by 160 · see citing works

Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

Salehi, A., Faizi, M., Colas, D., Valletta, J. S., Laguna, J., Takimoto‐Kimura, R., Kleschevnikov, A. M., Wagner, S. L., Aisen, P. S. S., Shamloo, M., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000258 · Cited by 159 · see citing works

Brain Plasticity and Disease: A Matter of Inhibition

Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Maffei, L., & Sale, A. (2011) · Neural Plasticity · doi:10.1155/2011/286073 · Cited by 160 · see citing works

Trafficking regulation of proteins in Alzheimer’s disease

Jiang, S., Li, Y., Zhang, X., Bu, G., Xu, H., & Zhang, Y. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-6 · Cited by 160 · see citing works

Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer’s Disease

Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167 · see citing works

TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia

Archbold, H. C., Jackson, K. L., Arora, A., Weskamp, K., Tank, E. M. H., Li, X., Miguez, R., Dayton, R. D., Tamir, S., Klein, R. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22858-w · Cited by 151 · see citing works

Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?

Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150 · see citing works

Down syndrome: searching for the genetic culprits

Lana-Elola, E., Watson-Scales, S., Fisher, E., & Tybulewicz, V. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008078 · Cited by 149 · see citing works

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of <i>APP</i>

Wiseman, F. K., Pulford, L. J., Barkus, C., Liao, F., Portelius, E., Webb, R., Chávez-Gutiérrez, L., Cleverley, K., Noy, S., Sheppard, O., et al. (2018) · Brain · doi:10.1093/brain/awy159 · Cited by 133 · see citing works

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer

Faizi, M., Bader, P. L., Tun, C., Encarnacion, A., Kleschevnikov, A. M., Belichenko, P. V., Saw, N. L., Priestley, M., Tsien, R. W., Mobley, W. C., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.011 · Cited by 134 · see citing works

Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.

Moon, J., Chen, M. W., Gandhy, S. U., Strawderman, M. S., Levitsky, D. A., Maclean, K. N., & Strupp, B. J. (2010) · Behavioral Neuroscience · doi:10.1037/a0019590 · Cited by 136 · see citing works

Glutamatergic synapses in neurodevelopmental disorders

Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 136 · see citing works

Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

Iulita, M. F., & Cuello, A. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.010 · Cited by 135 · see citing works

Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome

Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134 · see citing works

Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model

Das, I., Park, J. M., Shin, J. H., Jeon, S. K., Lorenzi, H., Linden, D. J., Worley, P. F., & Reeves, R. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005983 · Cited by 134 · see citing works

The challenge of Down syndrome

Antonarakis, S. E., & Epstein, C. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.005 · Cited by 134 · see citing works

Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

Ginsberg, S. D., Mufson, E. J., Alldred, M. J., Counts, S., Wuu, J., Nixon, R. A., & Che, S. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.05.012 · Cited by 133 · see citing works

Aneuploidy: from a physiological mechanism of variance to Down syndrome.

Dierssen, M., Hérault, Y., & Estivill, X. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2007 · Cited by 132 · see citing works

Regional Selectivity of rab5 and rab7 Protein Upregulation in Mild Cognitive Impairment and Alzheimer's Disease

Ginsberg, S. D., Mufson, E. J., Counts, S., Wuu, J., Alldred, M. J., Nixon, R. A., & Che, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101080 · Cited by 128 · see citing works

ProNGF and Neurodegeneration in Alzheimer’s Disease

Fahnestock, M. L., & Shekari, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00129 · Cited by 126 · see citing works

Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities

Gauthier, S. A., Pérez‐González, R., Sharma, A., Huang, F.-K., Alldred, M. J., Pawlik, M., Kaur, G., Ginsberg, S. D., Neubert, T. A., & Levy, E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0466-0 · Cited by 125 · see citing works

Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer’s Disease

Pensalfini, A., Kim, S., Subbanna, S., Bleiwas, C., Goulbourne, C. N., Stavrides, P. H., Jiang, Y., Lee, J., Darji, S., Pawlik, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108420 · Cited by 125 · see citing works

Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Gall, J., George, L., Nosheny, R., Maloney, M. T., Salehi, A., & Mobley, W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.009 · Cited by 124 · see citing works

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Alić, I., Goh, P. A., Murray, A., Portelius, E., Gkanatsiou, E., Gough, G., Mok, K. Y., Koschut, D., Brunmeir, R., Yeap, Y. J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0806-5 · Cited by 123 · see citing works

Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model

Lockrow, J. P., Prakasam, A., Huang, P., Bimonte‐Nelson, H. A., Sambamurti, K., & Granholm, A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.021 · Cited by 123 · see citing works

Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome

Velázquez, R., Ash, J. A., Powers, B. E., Kelley, C. M., Strawderman, M. S., Luscher, Z. I., Ginsberg, S. D., Mufson, E. J., & Strupp, B. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.016 · Cited by 118 · see citing works

Endosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases

Bronfman, F. C., Escudero, C. A., Weis, J., & Krüttgen, A. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20513 · Cited by 119 · see citing works

Cell cycle molecules define a pathway required for neuron death in development and disease

Greene, L. A., Liu, D. X., Troy, C. M., & Biswas, S. C. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.003 · Cited by 115 · see citing works

Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome

Lockrow, J. P., Boger, H. A., Bimonte‐Nelson, H. A., & Granholm, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.036 · Cited by 116 · see citing works

Mechanisms of neurotrophin trafficking via Trk receptors

Scott-Solomon, E., & Kuruvilla, R. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.013 · Cited by 113 · see citing works

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations

Gardiner, K. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s51476 · Cited by 114 · see citing works

Cofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies

Maloney, M. T., & Bamburg, J. R. (2007) · Molecular Neurobiology · doi:10.1007/bf02700622 · Cited by 112 · see citing works

Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel

Lana‐Elola, E., Watson-Scales, S., Slender, A., Gibbins, D., Martineau, A., Douglas, C., Mohun, T. J., Fisher, E., & Tybulewicz, V. L. J. (2016) · eLife · doi:10.7554/elife.11614 · Cited by 105 · see citing works

Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · see citing works

Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation

Alldred, M. J., Pidikiti, H., Heguy, A., Roussos, P., & Ginsberg, S. D. (2023) · The FASEB Journal · doi:10.1096/fj.202202111rr · Cited by 24 · see citing works

Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome

Hunter, C. L., Ole Isacson, A., Nelson, M., Bimonte‐Nelson, H. A., Seo, H., Lin, L., Ford, K. A., Kindy, M. S., & Granholm, A. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00005-1 · Cited by 80 · see citing works

P1–107: In vivo MRI correlates of specific cholinergic circuitry loss in murine models of Down syndrome

Dyakin, V. V., Chen, Y., Branch, C. A., Ardekani, B. A., Yang, D. S., Guilfoil, D. N., Peterson, J. N., Peterhoff, C., Cataldo, A. M., & Nixon, R. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.483

Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice

Seo, H., & Ole Isacson, A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.017 · Cited by 112 · see citing works